Medication info

Clavon Duo Dry Syrup [Amoxicillin-Potassium Clavulanate (7:1)]

Prescription medicationSyrupOral
Ingredient · strength
Amoxicillin Hydrate›36.3143g / 100gDilute Potassium Clavulanate›10.3756g / 100g
Manufacturer / importer
Guju Pharmaceutical Co., Ltd.
Appearance
A whitish powder with a peculiar smell, to be dissolved before use as syrup
Packaging
(For domestic use) 5.5g/50㎖ (For export) 3.85g/35㎖, 5.5g/50㎖, 7.7g/70㎖, 55g/500㎖
Approval status
Active

MFDS item code 201310677 · Notified 2013.12.13 · Insurance code 669804311

Summary

Main use
Treatment of respiratory and otorhinolaryngologic infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin-clavulanate is optimized when administered at the start of a meal.
Child dose
For mild to moderate infections such as upper respiratory tract infections including recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg per kg of body weight per day as amoxicillin/potassium clavulanate, taken in 2 divided doses. For severe infections such as upper respiratory tract infections including otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg per kg of body weight per day as amoxicillin/potassium clavulanate, taken in 2 divided doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal impairment.

Ingredients

Manufacturer
Guju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and otorhinolaryngologic infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar and bronchial pneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
  • gonorrhea
View approved original text

This drug is used to treat infections caused by various bacteria. It is effective for respiratory infections such as acute and chronic bronchitis, lobar and bronchial pneumonia, empyema, and lung abscess, as well as for tonsillitis, sinusitis, and otitis media. It also helps treat urinary tract infections such as cystitis, urethritis, and pyelonephritis. The drug is used for infections in various areas, including pelvic infections, gonorrhea, abscesses, soft tissue infections, wound infections, osteomyelitis, and dental infections. This drug is particularly effective against various bacteria, including beta-lactamase producing strains, and helps improve the infection status.

How to take

Adult dose

Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin-clavulanate is optimized when administered at the start of a meal.

Child dose

For mild to moderate infections such as upper respiratory tract infections including recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual dose is 25 mg/3.6 mg per kg of body weight per day as amoxicillin/potassium clavulanate, taken in 2 divided doses. For severe infections such as upper respiratory tract infections including otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual dose is 45 mg/6.4 mg per kg of body weight per day as amoxicillin/potassium clavulanate, taken in 2 divided doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal impairment.

Precautions

This medication contains the artificial sweetener aspartame, which is broken down into phenylalanine in the body. Therefore, patients with the genetic disorder phenylketonuria should not take this medication. The maximum daily allowable amount of aspartame is limited to less than 40mg/kg as per WHO recommendations, which translates to a maximum of 2.4g per day for adults. Patients who have had allergies to the ingredients in this medicine or beta-lactam antibiotics should not take it. It is also advisable for patients with infectious mononucleosis or lymphocytic leukemia to avoid this medication due to the risk of rash. Additionally, patients who have had liver dysfunction or jaundice due to this medication or penicillin in the past should avoid taking it. This medication contains lactose, so it should not be administered to patients with genetic problems such as galactose intolerance or lactase deficiency. Patients with poor liver function or severe kidney dysfunction should use this medication cautiously, and those with allergic tendencies should also be careful. If gastrointestinal diseases accompanied by vomiting or diarrhea occur during treatment, caution is needed as drug absorption may not occur properly. This medication may cause gastrointestinal adverse reactions such as diarrhea, gastritis, vomiting, and occasionally severe colitis or acute pancreatitis, so if symptoms occur, it is essential to stop taking the medication immediately and consult a doctor. Symptoms indicative of liver dysfunction have also been reported, so elderly patients or those on long-term treatment should undergo regular liver function tests. Rarely, serious allergic reactions such as skin rash, urticaria, and anaphylactic shock may occur; if these symptoms appear, stop using the medication immediately and seek emergency treatment. Blood tests may reveal abnormalities such as leukopenia, anemia, and thrombocytopenia with prolonged use, so regular blood testing is necessary. This medication may affect kidney function, so patients with kidney diseases require regular testing and must stop treatment immediately if abnormalities occur. Women who are pregnant or breastfeeding should use this medication with caution; particularly, it is advised to avoid use in the first three months of pregnancy. The safety of this medication in children, especially in neonates or premature infants under the age of 2 months, has not been established; therefore, it is crucial to consult a doctor before administration. Elderly patients may experience adverse reactions more easily due to decreased bodily functions; hence, dosage and intervals should be adjusted, and use should be cautious. During the use of this medication, it is essential to regularly check liver function, kidney function, and blood status; if any unusual symptoms arise after taking the drug, seek a doctor's evaluation immediately. Moreover, this medication may interact with other drugs, so it is vital to inform your healthcare provider of any other medications being taken. After administration, the medication should be shaken well, stored in a refrigerator after preparation, and consumed within 7 days.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black tongue
  • nausea
  • vomiting
  • anorexia
Show 78 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • soft stools
  • dry mouth
  • acute pancreatitis
  • candidiasis
  • antibiotic-induced colitis
  • blood in stool
  • itching
  • polymorphic eruption of pregnancy
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • bullous exfoliative dermatitis
  • acute generalized pustular dermatitis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vulvar itching
  • vaginal burning
  • increased discharge
  • anxiety
  • restlessness
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • antidystonic therapy
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute kidney failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • hypoprothrombinemia
  • bleeding tendency
  • symptoms of vitamin B deficiency
  • dysgeusia
  • malaise
  • dermatitis
  • oral edema
  • abdominal discomfort
  • fluid and electrolyte imbalance
  • rash
  • drowsiness
  • renal failure
  • epileptic seizures
  • hypersensitivity shock
  • skin reactions
  • bleeding
  • pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to protect it from air and moisture, and it is essential to maintain the storage temperature between 1 degree and 25 degrees. Proper storage will help maintain the efficacy of the medication and ensure its safe use.

Appearance and packaging

Appearance

A whitish powder with a peculiar smell, to be dissolved before use as syrup

Package unit

(For domestic use) 5.5g/50㎖ (For export) 3.85g/35㎖, 5.5g/50㎖, 7.7g/70㎖, 55g/500㎖

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.